Apr 18, 2024 13:25
ABVC - ABVC BioPharma, Inc. Common Stock
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
2.93 0.01 (0.34%) | --- | --- | 0.01 (0.34%) | 0.1 (3.41%) | -0.09 (-2.97%) | 0.0 (0.0%) | 0.0 (0.0%) |
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.06
- Diluted EPS:
- -0.06
- Basic P/E:
- -49.0
- Diluted P/E:
- -49.0
- RSI(14) 1m:
- 0.0
- VWAP:
- 2.94
- RVol:
- 0.2203
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
1m | Price increase 1m | 2.99 +0.06 (+2.05%) | Oct 15 13:00 |
1m | Price increase 1m | 3.03 +0.1 (+3.41%) | Oct 15 09:03 |
10m | Price increase 10m | 3.03 +0.1 (+3.41%) | Oct 15 09:03 |
Related News
Mar 26, 2024 12:30
Mar 14, 2024 13:30
Feb 08, 2024 14:17
Jan 04, 2024 18:37
Jan 04, 2024 12:59
Jan 03, 2024 17:58
Jan 03, 2024 12:24
Dec 07, 2023 13:30
Nov 21, 2023 18:28